DS

Dan T. Stinchcomb

TV Takeda Vaccines: 24 patents #1 of 44Top 3%
RP Ribozyme Pharmaceuticals: 20 patents #5 of 62Top 9%
HE Heska: 7 patents #20 of 88Top 25%
3P 3-Dimensional Pharmaceuticals: 2 patents #36 of 93Top 40%
CH Chiron: 2 patents #263 of 583Top 50%
IB Igm Biosciences: 2 patents #8 of 16Top 50%
WC Warner-Lambert Company: 2 patents #646 of 1,610Top 45%
ST Sirna Therapeutics: 1 patents #87 of 124Top 75%
📍 Enumclaw, WA: #1 of 111 inventorsTop 1%
🗺 Washington: #862 of 76,902 inventorsTop 2%
Overall (All Time): #42,145 of 4,157,543Top 2%
57
Patents All Time

Issued Patents All Time

Showing 26–50 of 57 patents

Patent #TitleCo-InventorsDate
8871487 Compositions, methods and uses for inducing viral growth Jill A. Livengood, O'Neil Wiggan, Richard M. Kinney, Jorge E. Osorio 2014-10-28
8088903 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof Kevin S. Brandt, Patrick J. Gaines, Nancy Wisnewski 2012-01-03
8084039 Methods and compositions for live attenuated viruses Jorge E. Osorio, O'Neil Wiggan 2011-12-27
8029776 Cationic lipid-mediated enhancement of nucleic acid immunization of cats Joel Haynes, Ramani S. Wonderling 2011-10-04
7314627 Cationic lipid-mediated enhancement of nucleic acid immunization of cats Joel Haynes, Ramani S. Wonderling 2008-01-01
7034009 Enzymatic nucleic acid-mediated treatment of ocular diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R) Pamela Pavco, James McSwiggen, Jaime Escobedo 2006-04-25
6770282 Cationic lipid-mediated enhancement of nucleic acid immunization of cats Joel Haynes, Ramani S. Wonderling 2004-08-03
6566127 Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor Pamela Pavco, James McSwiggen, Jaime Escobedo 2003-05-20
6518266 1- Aryl-3-thioalkyl pyrazoles, the synthesis thereof and the use thereof as insecticides Daljit S. Dhanoa, Dario Doller, Sanath K. Meegalla, Richard Soll, Nancy Wisnewski +4 more 2003-02-11
6506784 Use of 1,3-substituted pyrazol-5-yl sulfonates as pesticides Daljit S. Dhanoa, Dario Doller, Sanath K. Meegalla, Richard Soll, Dimitris Agrafiotis +3 more 2003-01-14
6436644 Ribozyme treatment of diseases or conditions related to levels of intercellular adhesion molecule-1 (CAM-1) Susan Grimm, James McSwiggen, Sean M. Sullivan, Kenneth G. Draper 2002-08-20
6410224 Ribozyme treatment of diseases or conditions related to levels of NF-&kgr;B Kenneth G. Draper, James McSwiggen 2002-06-25
6194150 Nucleic acid based inhibition of CD40 Thale Jarvis, James McSwiggen 2001-02-27
6159692 Method and reagent for inhibiting human immunodeficiency virus replication Kenneth G. Draper, Bharat Chowrira, James McSwiggen, James D. Thompson 2000-12-12
6132967 Ribozyme treatment of diseases or conditions related to levels of intercellular adhesion molecule-1 (ICAM-1) Susan Grimm, James McSwiggen, Sean M. Sullivan, Kenneth G. Draper 2000-10-17
6106841 Delivery method for recombinant raccoon poxvirus Jorge E. Osorio 2000-08-22
6103890 Enzymatic nucleic acids that cleave C-fos Thale Jarvis, James McSwiggen 2000-08-15
5972704 HIV nef targeted ribozymes Kenneth G. Draper, Bharat Chowrira, James McSwiggen, James D. Thompson 1999-10-26
5877021 B7-1 targeted ribozymes Thale Jarvis, James McSwiggen 1999-03-02
5877022 Ribozymes targeted to APO(a) RNA James McSwiggen, Roger Schofield Newton, Randy Ranjee Ramharack 1999-03-02
5837542 Intercellular adhesion molecule-1 (ICAM-1) ribozymes Susan Grimm, James McSwiggen, Sean M. Sullivan, Kenneth G. Draper 1998-11-17
5817796 C-myb ribozymes having 2'-5'-linked adenylate residues Kenneth G. Draper, James McSwiggen, Thale Jarvis 1998-10-06
5811300 TNF-.alpha. ribozymes Sean M. Sullivan, Kenneth G. Draper, Kevin Kisich, James McSwiggen 1998-09-22
5807743 Interleukin-2 receptor gamma-chain ribozymes James McSwiggen 1998-09-15
5731295 Method of reducing stromelysin RNA via ribozymes Kenneth G. Draper, Pamela Pavco, James McSwiggen, John Gustofson 1998-03-24